Integra Lifesciences Holdings CORP Form 4 insider transactions

Director Barbara Hill reports acquiring shares of Integra LifeSciences Holdings Corp through non-open market transactions.

Director Lo Renee Wonlai reports acquisition and disposal of Integra LifeSciences Holdings Corp (IART) common stock on May 9, 2024.

Director Raymond G. Murphy reports acquisition and disposal of Integra LifeSciences Holdings Corp (IART) common stock.

Director Christian S. Schade reports changes in beneficial ownership of Integra LifeSciences common stock, including acquisition of 8,696 shares and disposal of an unspecified amount on May 9, 2024.

Director Keith Bradley reported changes in beneficial ownership of Integra LifeSciences Holdings Corp shares, including acquisitions and disposals, according to a Form 4 filing.

CEO Jan De Witte reports acquisition and disposal of Integra LifeSciences Holdings Corp stock and derivative securities on March 11, 2024.

EVP & President, TT, Robert T. Davis Jr. of Integra LifeSciences Holdings Corp reports acquisition and disposal of common stock and stock options.

EVP & President, CSS, Michael J. McBreen, reports acquisition and disposal of Integra LifeSciences Holdings Corp shares, including stock options, on March 11-12, 2024.

Eric Schwartz, EVP, Chief Legal Officer & Secretary of Integra LifeSciences, reports transactions involving company stock, including acquisitions and disposals to cover tax obligations.

Chantal Veillon-Berteloot, EVP & CHRO of Integra LifeSciences, reports acquiring common stock and stock options.

Lea Daniels Knight, EVP & CFO of Integra LifeSciences, reports acquiring shares and stock options in the company on March 11, 2024.

EVP & President, International, Harvinder Singh, reports acquisition of stock options and restricted stock units in Integra LifeSciences Holdings Corp.

Jeffrey Mosebrook, SVP, Fin & Princ Acct Officer of Integra LifeSciences, reports transactions involving common stock, including acquisitions and disposals to cover tax obligations.

Robert T. Davis Jr., EVP & President, TT of Integra LifeSciences, disposed of 635 shares of common stock on March 10, 2024, to satisfy tax obligations.

Michael J. McBreen, EVP & President, CSS of Integra LifeSciences, reports disposition of shares to cover tax obligations.

Eric Schwartz, EVP, Chief Legal Officer & Secretary of Integra LifeSciences, reported disposing of 799 shares of common stock on March 10, 2024.

Jeffrey Mosebrook, SVP, Fin & Princ Acct Officer of Integra LifeSciences, reports the disposal of common stock to cover tax obligations.

CEO Jan De Witte reports the vesting and subsequent disposal of Integra LifeSciences Holdings Corp stock units to cover tax obligations.

EVP & President, International, Harvinder Singh, reports the vesting of restricted stock units and adjustments to previously reported holdings in Integra LifeSciences.

Robert T. Davis Jr., EVP & President, TT of Integra LifeSciences, sold shares to cover the exercise price and withholding taxes related to expiring stock options.